Search - tctmd.com

Displaying 401 - 420 of 1904

Sort: Relevancy | Date

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

June 08, 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

News Conference News LINC 2023

Good Real-World Outcomes Seen With Next-Generation Carotid Stent

June 06, 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

News Conference News ESC Heart Failure 2023

SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms

June 06, 2023

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

News Conference News HRS 2023

Serious Risks With ‘Jailing’ Pacemaker, ICD Leads During TTVR

Michael O'Riordan

June 05, 2023

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

News Conference News ESC Heart Failure 2023

Boosting GDMT and Improving Outcomes? No Mean Task After AHF

June 01, 2023

OPTIMAL-BP Shows Harm of Too Much BP-Lowering After Stroke Thrombectomy

News Conference News ESOC 2023

OPTIMAL-BP Shows Harm of Too Much BP-Lowering After Stroke Thrombectomy

June 01, 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

News Conference News SCAI 2023

SPIRIT 48: Long DES for Diffuse CAD Highly Deliverable, Safe at 1 Year

May 31, 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

May 30, 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

News Conference News ESOC 2023

ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy

May 26, 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

May 26, 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

ELAN: Early DOACs Safe, May Help After Ischemic Stroke in AF Patients

News Conference News ESOC 2023

ELAN: Early DOACs Safe, May Help After Ischemic Stroke in AF Patients

May 24, 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

May 24, 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

News Conference News ESC Heart Failure 2023

Loop Diuretics Are Heavily Prescribed Outside of HF: That’s a Problem

May 23, 2023

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

News Conference News EAS 2023

High LDL, Poor Treatment, Early Death: HoFH Registry Paints Grim Picture

Michael O'Riordan

May 23, 2023

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

News Conference News ESC Heart Failure 2023

More ARNI Insights Fortify Role in ‘Below Normal’ LVEF: PARAGLIDE-HF

May 22, 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

May 22, 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

News Conference News SCAI 2023

FLASH: PE Patients Show Ongoing Clinical, QoL Gains With Thrombectomy

May 21, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.